Boswellic acid has anti‐inflammatory effects and enhances the anticancer activities of Temozolomide and Afatinib, an irreversible ErbB family blocker, in human glioblastoma cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Boswellic acid has anti‐inflammatory effects and enhances the anticancer activities of Temozolomide and Afatinib, an irreversible ErbB family blocker, in human glioblastoma cells
Authors
Keywords
-
Journal
PHYTOTHERAPY RESEARCH
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-03-29
DOI
10.1002/ptr.6354
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study
- (2018) Armine Haroyan et al. BMC Complementary and Alternative Medicine
- Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic Development
- (2018) Zev A. Binder et al. CANCER CELL
- Novel nanohydrogel of hyaluronic acid loaded with quercetin alone and in combination with temozolomide as new therapeutic tool, CD44 targeted based, of glioblastoma multiforme
- (2018) Manlio Barbarisi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The prognosis for patients with newly diagnosed glioblastoma receiving bevacizumab combination therapy: a meta-analysis
- (2018) Ke-Li Liao et al. OncoTargets and Therapy
- Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production
- (2018) Gennaro Riccio et al. Frontiers in Physiology
- Cardioprotective Effects of Nanoemulsions Loaded with Anti-Inflammatory Nutraceuticals against Doxorubicin-Induced Cardiotoxicity
- (2018) Vincenzo Quagliariello et al. Nutrients
- Chemoresistance caused by the microenvironment of glioblastoma and the corresponding solutions
- (2018) Xin Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Hyaluronic Acid Nanohydrogel Loaded With Quercetin Alone or in Combination to a Macrolide Derivative of Rapamycin RAD001 (Everolimus) as a New Treatment for Hormone-Responsive Human Breast Cancer
- (2017) Vincenzo Quagliariello et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The role of bevacizumab in the treatment of glioblastoma
- (2017) Roberto Jose Diaz et al. JOURNAL OF NEURO-ONCOLOGY
- A TNF–JNK–Axl–ERK signaling axis mediates primary resistance to EGFR inhibition in glioblastoma
- (2017) Gao Guo et al. NATURE NEUROSCIENCE
- The Impact of the Tumor Microenvironment on the Properties of Glioma Stem-Like Cells
- (2017) Alessandra Audia et al. Frontiers in Oncology
- Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitors
- (2016) Nicola Maurea et al. Journal of Cardiovascular Medicine
- Curcumin bioavailability from oil in water nano-emulsions: In vitro and in vivo study on the dimensional, compositional and interactional dependence
- (2016) Raffaele Vecchione et al. JOURNAL OF CONTROLLED RELEASE
- Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter survey
- (2016) Massimiliano Berretta et al. Oncotarget
- NF-κB inhibitor reverses temozolomide resistance in human glioma TR/U251 cells
- (2015) XUAN WANG et al. Oncology Letters
- Afatinib, an irreversible ErbB family blocker, with protracted temozolomide in recurrent glioblastoma: A case report
- (2015) Jad Alshami et al. Oncotarget
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neuroprotection by Acetyl-11-Keto-β-Boswellic Acid, in Ischemic Brain Injury Involves the Nrf2/HO-1 defense Pathway
- (2014) Yi Ding et al. Scientific Reports
- Cross-linked hyaluronic acid sub-micron particles: in vitro and in vivo biodistribution study in cancer xenograft model
- (2013) F. Rosso et al. JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
- Targeted Therapy Resistance Mediated by Dynamic Regulation of Extrachromosomal Mutant EGFR DNA
- (2013) David A. Nathanson et al. SCIENCE
- Boswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and miR-200 microRNA family
- (2012) M. Takahashi et al. CARCINOGENESIS
- Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance
- (2012) T. E. Taylor et al. CURRENT CANCER DRUG TARGETS
- Enhanced absorption of boswellic acids by a lecithin delivery form (Phytosome®) of Boswellia extract
- (2012) Jan Hüsch et al. FITOTERAPIA
- Leukotriene B4Receptor-2 Promotes Invasiveness and Metastasis of Ovarian Cancer Cells through Signal Transducer and Activator of Transcription 3 (STAT3)-dependent Up-regulation of Matrix Metalloproteinase 2
- (2012) Ji-Min Seo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Quercetin Reduces Inflammatory Responses in LPS-Stimulated Cardiomyoblasts
- (2012) Cristina Angeloni et al. Oxidative Medicine and Cellular Longevity
- Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors
- (2011) Simon Kirste et al. CANCER
- Nutraceutical use in late-stage cancer
- (2010) Michael J. Wargovich et al. CANCER AND METASTASIS REVIEWS
- MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib
- (2010) Manik Chahal et al. NEURO-ONCOLOGY
- Therapeutic Inhibition of the Epidermal Growth Factor Receptor in High-Grade Gliomas: Where Do We Stand?
- (2009) G. Karpel-Massler et al. MOLECULAR CANCER RESEARCH
- BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models
- (2008) D Li et al. ONCOGENE
- Boswellic acids: A leukotriene inhibitor also effective through topical application in inflammatory disorders
- (2008) S. Singh et al. PHYTOMEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now